Diffuse midline glioma (DMG) is a uniformly fatal pediatric cancer driven by oncohistones that do not readily lend themselves to drug development. To identify druggable targets for DMG, we conducted a genome-wide CRISPR screen that reveals a DMG selective dependency on the de novo pathway for pyrimidine biosynthesis. This metabolic vulnerability reflects an elevated rate of uridine/uracil degradation that depletes DMG cells of substrates for the alternate salvage pyrimidine biosynthesis pathway. A clinical stage inhibitor of DHODH (rate-limiting enzyme in the de novo pathway) diminishes uridine-5'-phosphate (UMP) pools, generates DNA damage, and induces apoptosis through suppression of replication forks-an "on-target" effect, as shown by uridine rescue. Matrix-assisted laser desorption/ionization (MALDI) mass spectroscopy imaging demonstrates that this DHODH inhibitor (BAY2402234) accumulates in the brain at therapeutically relevant concentrations, suppresses de novo pyrimidine biosynthesis in vivo, and prolongs survival of mice bearing intracranial DMG xenografts, highlighting BAY2402234 as a promising therapy against DMGs.
Pubmed ID: 35985342 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets DHODH
View all literature mentionsThis monoclonal targets Histone H2A.X pSer139
View all literature mentionsThis monoclonal secondary targets IgG
View all literature mentionsThis unknown targets IgG
View all literature mentionsThis monoclonal targets autoimmune single stranded DNA
View all literature mentionsThis polyclonal targets Cleaved Caspase-3 (Asp175)
View all literature mentionsThis monoclonal targets beta-actin
View all literature mentionsThis monoclonal targets Cleaved PARP (Asp214)
View all literature mentionsThis polyclonal targets Phospho-Histone H2A.X (Ser139)
View all literature mentionsThis monoclonal targets H2A.X Phospho Ser139
View all literature mentionsThis unknown targets Phospho-RPA32 (Ser33)
View all literature mentionsThis polyclonal targets Rat Rat IgG secondary - H&L
View all literature mentionsThis polyclonal targets Mouse Mouse IgG secondary - H&L
View all literature mentionsThis monoclonal targets BrdU
View all literature mentionsThis monoclonal targets RPA32/RPA2
View all literature mentionsThis unknown targets RPA32/RPA2 (phospho T21)
View all literature mentionsThis recombinant monoclonal targets DPD
View all literature mentionsView all literature mentions
Mus musculus with name NOD.Cg-Prkdcscid Il2rg